Who owns Oramed Pharm?
- Ticker: ORMP
- CUSIP Number: 68403P203
Tip: Access positions for across all investors
Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Oramed Pharm stock
Who bought or sold Oramed Pharm this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 3.2M | $11M | 0% | Mar 2026 |
|
| Aquamarine Financial | 2.0M | $5.6M | 0% | Dec 2025 |
|
| Mercer Global Advisors | 1.9M | $6.5M | 100% | Mar 2026 |
|
| SB Capital Management | 1.9M | $5.4M | 100% | Dec 2025 |
|
| Murchinson | 1.3M | $4.5M | -2% | Mar 2026 |
|
| Boothbay Fund Management | 601k | $2.0M | -2% | Mar 2026 |
|
| Marshall Wace | 259k | $738k | 100% | Dec 2025 |
|
| Rathbones Brothers | 233k | $792k | 0% | Mar 2026 |
|
| Dimensional Fund Advisors | 158k | $538k | 5% | Mar 2026 |
|
| Wells Fargo & Company | 158k | $536k | 21% | Mar 2026 |
|
| Comprehensive Portfolio Management | 156k | $529k | 100% | Mar 2026 |
|
| Renaissance Technologies | 148k | $420k | -1% | Dec 2025 |
|
| Bank of America Corporation | 146k | $497k | 100% | Mar 2026 |
|
| O'shaughnessy Asset Management | 116k | $396k | 100% | Mar 2026 |
|
| Citadel Advisors | 99k | $335k | -50% | Mar 2026 |
|
| Hillsdale Investment Management | 97k | $331k | 100% | Mar 2026 |
|
| BlackRock | 92k | $313k | 2% | Mar 2026 |
|
| Jane Street | 53k | $179k | -33% | Mar 2026 |
|
| Hudson Bay Capital Management | 52k | $176k | 100% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 50k | $171k | 15% | Mar 2026 |
|
| Quadrature Capital | 42k | $119k | 100% | Dec 2025 |
|
| XTX Topco | 38k | $109k | 60% | Dec 2025 |
|
| Bailard | 33k | $110k | 100% | Mar 2026 |
|
| Hrt Financial | 28k | $93k | -40% | Mar 2026 |
|
| Point72 Asset Management | 26k | $89k | 2% | Mar 2026 |
|
| Susquehanna International | 26k | $74k | -29% | Dec 2025 |
|
| Geode Capital Management | 24k | $83k | 0% | Mar 2026 |
|
| Catalyst Funds Management Pty | 24k | $80k | 100% | Mar 2026 |
|
| Redwood Family Wealth | 22k | $75k | -4% | Mar 2026 |
|
| Springbok Capital Management | 22k | $62k | 100% | Dec 2025 |
|
| Pnc Financial Services | 21k | $72k | 0% | Mar 2026 |
|
| American Century Companies | 20k | $56k | 0% | Dec 2025 |
|
| Algert Coldiron Investors | 19k | $65k | 59% | Mar 2026 |
|
| OMERS Administration Corporation | 18k | $63k | 100% | Mar 2026 |
|
| Sage Capital Management | 18k | $61k | 7% | Mar 2026 |
|
| Millennium Management | 16k | $55k | 100% | Mar 2026 |
|
| Kathmere Capital Management | 15k | $51k | 100% | Mar 2026 |
|
| Acadian Asset Management | 15k | $50k | 100% | Mar 2026 |
|
| Morgan Stanley | 14k | $48k | -20% | Mar 2026 |
|
| Close Asset Management | 12k | $40k | 0% | Mar 2026 |
|
| UBS Group | 12k | $40k | 353% | Mar 2026 |
|
| Axq Capital | 11k | $39k | 100% | Mar 2026 |
|
| Altshuler Shaham | 11k | $38k | 0% | Mar 2026 |
|
| Glass Jacobson Investment Advisors | 11k | $36k | 0% | Mar 2026 |
|
| Citigroup | 9.0k | $31k | 100% | Mar 2026 |
|
| Steward Partners Investment Advisory | 8.8k | $30k | -5% | Mar 2026 |
|
| Barclays | 6.9k | $20k | -48% | Dec 2025 |
|
| Advisor Group Holdings | 4.3k | $12k | 0% | Dec 2025 |
|
| N.E.W. Advisory Services | 3.4k | $12k | 7% | Mar 2026 |
|
| Huntington National Bank | 3.0k | $8.6k | 0% | Dec 2025 |
|
| Pioneer Family Office | 3.0k | $10k | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 2.1k | $7.0k | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 1.6k | $5.4k | -8% | Mar 2026 |
|
| Simplex Trading | 1.1k | $3.3k | 100% | Dec 2025 |
|
| McIlrath & Eck | 1.0k | $3.4k | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 714.00 | $2.0k | 0% | Dec 2025 |
|
| Tower Research Capital | 693.00 | $2.0k | 100% | Dec 2025 |
|
| IFP Advisors | 500.00 | $1.7k | 0% | Mar 2026 |
|
| FMR | 500.00 | $1.4k | 0% | Dec 2025 |
|
| Golden State Wealth Management | 303.00 | $1.0k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 174.00 | $999.995400 | -95% | Mar 2026 |
|
| SBI Securities | 59.00 | $201.001200 | -96% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $7.000000 | 100% | Mar 2026 |
|
Who sold out of Oramed Pharm?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Dec 2025 | 58k | $166k |
| Rbf Capital | Dec 2025 | 43k | $122k |
| Two Sigma Securities | Dec 2025 | 23k | $66k |
| Wealth Enhancement Advisory Services | Dec 2025 | 18k | $56k |
| LPL Financial | Dec 2025 | 13k | $38k |
| Mariner Wealth Advisors | Dec 2025 | 11k | $31k |
| Caitlin John | Dec 2025 | 1.0k | $2.9k |
| Hanson McClain Advisors | Sep 2025 | 300.00 | $792.000000 |
| Jpmorgan Chase & Co | Sep 2025 | 170.00 | $449.089000 |